BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Metabolism of xenobiotics, Obesity, Hippocampus, Personalized medicine, Fluoxetine)
Bookmark Forward

QuickView for L-glutamate transmembrane transporter activity (biogroup)


Body Atlas

Most Correlated Tissues

  1. Pons
  2. Occipital lobe
  3. Temporal lobe
  4. Frontal lobe
  5. Parietal lobe
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Methicillin resistant Staphylococcus aureus infection
  2. Pyloric ulcer
  3. Vesicular stomatitis Indiana virus disease
  4. Citrullinemia
  5. Alpha-1-antitrypsin deficiency
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. CGP 60474
  2. NVP-BHG712
  3. ((3Z)-N-(3-chlorophenyl)-3-((3,5-dimethyl-4-((4-methylpiperazin-1-yl)carbonyl)-1H-pyrrol-2-yl)methylene)-N-methyl-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide)
  4. AST-1306
  5. Glial Cell Line-Derived Neurotrophic Factor
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. MIR517A
  2. SP5
  3. PAN2
  4. FN1
  5. HEY2
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

  1. L1000 CMAP - Prostate cancer PC3.101 cells with CRISPR-targeted gene knockouts
  2. The Cancer Genome Atlas (TCGA) - gene expression in glioblastoma multiforme
  3. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
  4. Immune cell miRNA profiles of isolated exosomes and donor cells
  5. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
Explore Curated Studies Results

Literature

Most Relevant Literature

There were no matches for L-glutamate transmembrane transporter activity
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Assessment the Activity Value of Isotretinoin (13- Cis-Retinoic Acid ) in the Treatment of COVID-19 …
  2. Combination Therapy With Isotretinoin and Tamoxifen Expected to Provide Complete Protection Against …
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.